Historical record - last NADAC effective date: 8/17/2022
Product Information
VORICONAZOLE 200 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.8024 per EA under NDC 43386008903. Its NADAC has been published 294 times since Jan 4, 2017.
FDA first approved this application on May 24, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386008903
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/17/2022
Active Ingredients
VORICONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207371FDA Approved
5/24/2016
TE Code
AB
On Market Since
5/24/2016
Pharmacological Classes
Price Statistics
The NADAC for VORICONAZOLE 200 MG TABLET has been published 294 times since Jan 4, 2017, and over the history we have for it it has declined 86.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8024 per EA |
|---|---|
| All-time high | $13.7046 (Jan 11, 2017) |
| All-time low | $1.8024 (Aug 17, 2022) |
| Median price | $5.2256 |
| Average price | $5.3667 |
| Largest weekly change | -61.5% (Jun 23, 2021) |
| Weeks tracked | 294 |
| Tracking since | Jan 4, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-42.5%
All
-86.8%
Last surveyed Aug 17, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VORICONAZOLE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VORICONAZOLE 200 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $1.8024 per EA (NDC 43386008903), effective Aug 17, 2022.
How has the price of VORICONAZOLE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for VORICONAZOLE 200 MG TABLET has declined 86.8%. It has been tracked across 294 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for VORICONAZOLE 200 MG TABLET?
Since Jan 4, 2017, the NADAC for VORICONAZOLE 200 MG TABLET has ranged from a low of $1.8024 (Aug 17, 2022) to a high of $13.7046 (Jan 11, 2017), with a median of $5.2256 per EA.
Are there cheaper alternatives to VORICONAZOLE 200 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VORICONAZOLE 200 MG TABLET, is $1.5586 per EA — about 14% below VORICONAZOLE 200 MG TABLET.
Who manufactures VORICONAZOLE 200 MG TABLET?
VORICONAZOLE 200 MG TABLET (NDC 43386008903) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.